Skip to main content

The Center on Health Services Training and Research (CoHSTAR) has opened its latest call for a full-time postdoctoral fellow—this time for a project related to postacute stroke services.

The 2-year position, to be located at the University of Pittsburgh, will begin in January 2019. Qualifications for consideration include being a physical therapist with an advanced degree (PhD, ScD, DrPH) completed in the last 5 years and status as a US citizen or noncitizen national. Individuals with strong analytic and writing skills and experience with the analysis of claims data, electronic health record data, and other large data are preferred.

The successful candidate will work with the Comprehensive Post-Acute Stroke Services (COMPASS) trial, a clinician-led quality improvement model providing early supported discharge and transitional care for individuals who have had a stroke and have been discharged home. The study is entering its fourth year and has produced a wealth of data that provides opportunities for secondary analyses. This fellowship will focus on data related to uptake of rehabilitation care and associated outcomes.

APTA was a major financial contributor to CoHSTAR, having donated $1 million toward the center's startup in 2015. In addition to APTA’s contribution, funding for CoHSTAR came from gifts from 50 APTA components, as well as foundations, corporations, and individual physical therapists. The Foundation for Physical Therapy also awarded the center a $2.5 grant.


You Might Also Like...

Review

Employer Noncompete Restrictions Eliminated in New Rule

Apr 26, 2024

In a sweeping decision already facing legal challenges, the FTC prohibits most noncompete clauses "whether written or communicated orally."

News

CMS Issues Final Rule on SNF Minimum Staffing

Apr 24, 2024

Nursing homes will be required to provide at least 3.48 hours of daily nursing care per resident, per day.

News

CMS Delays Startup of Problematic Restrictions on Access to Research Data

Apr 24, 2024

The new policy, which faces strong opposition from researchers, will be put on hold while CMS reviews "comments and concerns."